nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—EDNRA—migraine	0.482	1	CbGaD
Irbesartan—UGT1A3—Valproic Acid—migraine	0.0884	0.266	CbGbCtD
Irbesartan—PTGS1—Valproic Acid—migraine	0.0281	0.0842	CbGbCtD
Irbesartan—CYP2C8—Amitriptyline—migraine	0.0178	0.0533	CbGbCtD
Irbesartan—CYP2C8—Valproic Acid—migraine	0.0162	0.0486	CbGbCtD
Irbesartan—CYP1A2—Propranolol—migraine	0.0159	0.0477	CbGbCtD
Irbesartan—CYP2D6—Timolol—migraine	0.0147	0.0441	CbGbCtD
Irbesartan—CYP2C8—Verapamil—migraine	0.0141	0.0423	CbGbCtD
Irbesartan—CYP1A2—Amitriptyline—migraine	0.0138	0.0413	CbGbCtD
Irbesartan—CYP2D6—Propranolol—migraine	0.0131	0.0393	CbGbCtD
Irbesartan—CYP1A2—Valproic Acid—migraine	0.0125	0.0376	CbGbCtD
Irbesartan—CYP2C9—Amitriptyline—migraine	0.0124	0.0372	CbGbCtD
Irbesartan—CYP2D6—Amitriptyline—migraine	0.0113	0.034	CbGbCtD
Irbesartan—CYP2C9—Valproic Acid—migraine	0.0113	0.0339	CbGbCtD
Irbesartan—CYP1A2—Verapamil—migraine	0.0109	0.0328	CbGbCtD
Irbesartan—CYP2C9—Verapamil—migraine	0.00983	0.0295	CbGbCtD
Irbesartan—CYP2D6—Verapamil—migraine	0.00899	0.027	CbGbCtD
Irbesartan—CYP3A4—Propranolol—migraine	0.00833	0.025	CbGbCtD
Irbesartan—CYP3A4—Amitriptyline—migraine	0.0072	0.0216	CbGbCtD
Irbesartan—CYP3A4—Valproic Acid—migraine	0.00657	0.0197	CbGbCtD
Irbesartan—CYP3A4—Topiramate—migraine	0.00593	0.0178	CbGbCtD
Irbesartan—CYP3A4—Verapamil—migraine	0.00572	0.0172	CbGbCtD
Irbesartan—JUN—peripheral nervous system—migraine	0.00213	0.129	CbGeAlD
Irbesartan—JUN—nerve—migraine	0.00166	0.1	CbGeAlD
Irbesartan—JUN—blood vessel—migraine	0.0013	0.0787	CbGeAlD
Irbesartan—AGTR1—blood vessel—migraine	0.00098	0.0593	CbGeAlD
Irbesartan—JUN—neck—migraine	0.000931	0.0563	CbGeAlD
Irbesartan—EDNRA—trigeminal ganglion—migraine	0.000881	0.0533	CbGeAlD
Irbesartan—JUN—trigeminal ganglion—migraine	0.000804	0.0486	CbGeAlD
Irbesartan—JUN—brainstem—migraine	0.000711	0.043	CbGeAlD
Irbesartan—AGTR1—neck—migraine	0.000701	0.0424	CbGeAlD
Irbesartan—JUN—cardiovascular system—migraine	0.000581	0.0351	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—migraine	0.000437	0.0264	CbGeAlD
Irbesartan—PTGS1—blood vessel—migraine	0.000431	0.0261	CbGeAlD
Irbesartan—JUN—head—migraine	0.000393	0.0238	CbGeAlD
Irbesartan—JUN—nervous system—migraine	0.000373	0.0225	CbGeAlD
Irbesartan—JUN—central nervous system—migraine	0.000359	0.0217	CbGeAlD
Irbesartan—JUN—cerebellum—migraine	0.000351	0.0212	CbGeAlD
Irbesartan—Losartan—ACE—migraine	0.000349	1	CrCbGaD
Irbesartan—EDNRA—brain—migraine	0.000312	0.0189	CbGeAlD
Irbesartan—AGTR1—head—migraine	0.000296	0.0179	CbGeAlD
Irbesartan—JUN—brain—migraine	0.000285	0.0172	CbGeAlD
Irbesartan—AGTR1—nervous system—migraine	0.000281	0.017	CbGeAlD
Irbesartan—AGTR1—central nervous system—migraine	0.00027	0.0163	CbGeAlD
Irbesartan—AGTR1—brain—migraine	0.000215	0.013	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—migraine	0.000211	0.0127	CbGeAlD
Irbesartan—CYP2D6—brainstem—migraine	0.000194	0.0117	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—migraine	0.000192	0.0116	CbGeAlD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000159	0.0031	CbGpPWpGaD
Irbesartan—JUN—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000157	0.00307	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR1D—migraine	0.000157	0.00306	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000157	0.00305	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—HTR1A—migraine	0.000156	0.00305	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—ESR1—migraine	0.000156	0.00305	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CALCRL—migraine	0.000155	0.00303	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—RAMP1—migraine	0.000155	0.00303	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TAC1—migraine	0.000154	0.00301	CbGpPWpGaD
Irbesartan—JUN—Endothelins—FOS—migraine	0.000153	0.00299	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000153	0.00298	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000152	0.00297	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—FOS—migraine	0.000151	0.00295	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000151	0.00295	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000151	0.00295	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000151	0.00294	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000151	0.00294	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.00015	0.00293	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—TGFBR2—migraine	0.000149	0.00291	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000148	0.00288	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000148	0.00288	CbGpPWpGaD
Irbesartan—JUN—TSH signaling pathway—FOS—migraine	0.000148	0.00288	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—FOS—migraine	0.000148	0.00288	CbGpPWpGaD
Irbesartan—JUN—BCR signaling pathway—FOS—migraine	0.000146	0.00284	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR2B—migraine	0.000146	0.00284	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000145	0.00284	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—FOS—migraine	0.000144	0.00281	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—CALCA—migraine	0.000142	0.00278	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CALCRL—migraine	0.000141	0.00275	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—RAMP1—migraine	0.000141	0.00275	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—FOS—migraine	0.000141	0.00275	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00014	0.00273	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.000139	0.00271	CbGpPWpGaD
Irbesartan—EDNRA—G alpha (q) signalling events—HTR2A—migraine	0.000137	0.00267	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000135	0.00264	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000133	0.0026	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000133	0.00259	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000132	0.00257	CbGpPWpGaD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000131	0.00256	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFBR2—migraine	0.00013	0.00254	CbGpPWpGaD
Irbesartan—PTGS1—head—migraine	0.00013	0.00787	CbGeAlD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000129	0.00252	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NPS—migraine	0.000126	0.00245	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.000125	0.00244	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000125	0.00243	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—FOS—migraine	0.000124	0.00242	CbGpPWpGaD
Irbesartan—PTGS1—nervous system—migraine	0.000123	0.00746	CbGeAlD
Irbesartan—JUN—Circadian rythm related genes—SLC6A4—migraine	0.000123	0.00241	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000122	0.00239	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—RAMP1—migraine	0.000122	0.00238	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CALCRL—migraine	0.000122	0.00238	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR1B—migraine	0.000121	0.00236	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000121	0.00235	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00012	0.00234	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000119	0.00233	CbGpPWpGaD
Irbesartan—PTGS1—central nervous system—migraine	0.000119	0.00719	CbGeAlD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000118	0.00231	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000118	0.00231	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000118	0.00231	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000117	0.00229	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000117	0.00228	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—BDNF—migraine	0.000117	0.00228	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR1A—migraine	0.000116	0.00227	CbGpPWpGaD
Irbesartan—CYP2C8—brain—migraine	0.000116	0.00703	CbGeAlD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000116	0.00226	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—FOS—migraine	0.000115	0.00225	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—NPS—migraine	0.000115	0.00224	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—TAC1—migraine	0.000115	0.00224	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—FOS—migraine	0.000114	0.00223	CbGpPWpGaD
Irbesartan—JUN—FAS pathway and Stress induction of HSP regulation—TNF—migraine	0.000114	0.00222	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—TNF—migraine	0.000114	0.00222	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000113	0.00221	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR1D—migraine	0.000113	0.0022	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000113	0.0022	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—HTR2C—migraine	0.000112	0.00219	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000111	0.00217	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—RAMP1—migraine	0.000111	0.00216	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CALCRL—migraine	0.000111	0.00216	CbGpPWpGaD
Irbesartan—Mediastinal disorder—Gabapentin—migraine	0.00011	0.000942	CcSEcCtD
Irbesartan—Diarrhoea—Propranolol—migraine	0.00011	0.00094	CcSEcCtD
Irbesartan—Chills—Gabapentin—migraine	0.00011	0.000938	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—BDNF—migraine	0.00011	0.00214	CbGpPWpGaD
Irbesartan—Arthralgia—Valproic Acid—migraine	0.00011	0.000935	CcSEcCtD
Irbesartan—Chest pain—Valproic Acid—migraine	0.00011	0.000935	CcSEcCtD
Irbesartan—Myalgia—Valproic Acid—migraine	0.00011	0.000935	CcSEcCtD
Irbesartan—Anxiety—Valproic Acid—migraine	0.000109	0.000932	CcSEcCtD
Irbesartan—Hypersensitivity—Verapamil—migraine	0.000109	0.000931	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000109	0.000928	CcSEcCtD
Irbesartan—Epistaxis—Topiramate—migraine	0.000108	0.000924	CcSEcCtD
Irbesartan—Discomfort—Valproic Acid—migraine	0.000108	0.000924	CcSEcCtD
Irbesartan—JUN—Circadian rythm related genes—HTR7—migraine	0.000108	0.00211	CbGpPWpGaD
Irbesartan—Vision blurred—Timolol—migraine	0.000108	0.000921	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—TGFBR2—migraine	0.000107	0.0021	CbGpPWpGaD
Irbesartan—AGTR1—G alpha (q) signalling events—HTR2A—migraine	0.000107	0.00209	CbGpPWpGaD
Irbesartan—Agranulocytosis—Topiramate—migraine	0.000107	0.000915	CcSEcCtD
Irbesartan—Dry mouth—Valproic Acid—migraine	0.000107	0.000914	CcSEcCtD
Irbesartan—CYP2D6—head—migraine	0.000107	0.00647	CbGeAlD
Irbesartan—Erythema—Gabapentin—migraine	0.000107	0.00091	CcSEcCtD
Irbesartan—Malnutrition—Gabapentin—migraine	0.000107	0.00091	CcSEcCtD
Irbesartan—JUN—MyD88-independent cascade—FOS—migraine	0.000107	0.00208	CbGpPWpGaD
Irbesartan—Dizziness—Propranolol—migraine	0.000107	0.000909	CcSEcCtD
Irbesartan—Asthenia—Verapamil—migraine	0.000106	0.000907	CcSEcCtD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000106	0.00207	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000106	0.00206	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CALCA—migraine	0.000105	0.00205	CbGpPWpGaD
Irbesartan—Flatulence—Gabapentin—migraine	0.000105	0.000897	CcSEcCtD
Irbesartan—Oedema—Valproic Acid—migraine	0.000105	0.000896	CcSEcCtD
Irbesartan—Anaphylactic shock—Valproic Acid—migraine	0.000105	0.000896	CcSEcCtD
Irbesartan—Bradycardia—Topiramate—migraine	0.000105	0.000896	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2B—migraine	0.000105	0.00205	CbGpPWpGaD
Irbesartan—Pruritus—Verapamil—migraine	0.000105	0.000894	CcSEcCtD
Irbesartan—Tension—Gabapentin—migraine	0.000105	0.000893	CcSEcCtD
Irbesartan—Angioedema—Timolol—migraine	0.000105	0.000893	CcSEcCtD
Irbesartan—Dysgeusia—Gabapentin—migraine	0.000105	0.000891	CcSEcCtD
Irbesartan—Infection—Valproic Acid—migraine	0.000104	0.00089	CcSEcCtD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000104	0.00203	CbGpPWpGaD
Irbesartan—Nervousness—Gabapentin—migraine	0.000104	0.000884	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—BDNF—migraine	0.000103	0.00202	CbGpPWpGaD
Irbesartan—Rhinitis—Topiramate—migraine	0.000103	0.000882	CcSEcCtD
Irbesartan—Hepatitis—Topiramate—migraine	0.000103	0.00088	CcSEcCtD
Irbesartan—CYP3A4—nervous system—migraine	0.000103	0.00623	CbGeAlD
Irbesartan—Nervous system disorder—Valproic Acid—migraine	0.000103	0.000879	CcSEcCtD
Irbesartan—Vertigo—Timolol—migraine	0.000103	0.000878	CcSEcCtD
Irbesartan—Thrombocytopenia—Valproic Acid—migraine	0.000103	0.000877	CcSEcCtD
Irbesartan—Syncope—Timolol—migraine	0.000103	0.000877	CcSEcCtD
Irbesartan—Hypoaesthesia—Topiramate—migraine	0.000103	0.000875	CcSEcCtD
Irbesartan—Muscle spasms—Gabapentin—migraine	0.000103	0.000875	CcSEcCtD
Irbesartan—Tachycardia—Valproic Acid—migraine	0.000103	0.000875	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—HTR1D—migraine	0.000102	0.002	CbGpPWpGaD
Irbesartan—Vomiting—Propranolol—migraine	0.000102	0.000874	CcSEcCtD
Irbesartan—Pharyngitis—Topiramate—migraine	0.000102	0.000873	CcSEcCtD
Irbesartan—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000102	0.00199	CbGpPWpGaD
Irbesartan—Skin disorder—Valproic Acid—migraine	0.000102	0.000871	CcSEcCtD
Irbesartan—Urinary tract disorder—Topiramate—migraine	0.000102	0.000869	CcSEcCtD
Irbesartan—JUN—ErbB1 downstream signaling—FOS—migraine	0.000102	0.00199	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—FOS—migraine	0.000102	0.00199	CbGpPWpGaD
Irbesartan—Oedema peripheral—Topiramate—migraine	0.000102	0.000867	CcSEcCtD
Irbesartan—Hyperhidrosis—Valproic Acid—migraine	0.000102	0.000866	CcSEcCtD
Irbesartan—Rash—Propranolol—migraine	0.000102	0.000866	CcSEcCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000102	0.00198	CbGpPWpGaD
Irbesartan—Dermatitis—Propranolol—migraine	0.000101	0.000866	CcSEcCtD
Irbesartan—CYP2D6—nervous system—migraine	0.000101	0.00613	CbGeAlD
Irbesartan—Diarrhoea—Verapamil—migraine	0.000101	0.000865	CcSEcCtD
Irbesartan—Connective tissue disorder—Topiramate—migraine	0.000101	0.000865	CcSEcCtD
Irbesartan—Urethral disorder—Topiramate—migraine	0.000101	0.000862	CcSEcCtD
Irbesartan—Loss of consciousness—Timolol—migraine	0.000101	0.000859	CcSEcCtD
Irbesartan—Vision blurred—Gabapentin—migraine	0.000101	0.000858	CcSEcCtD
Irbesartan—Anorexia—Valproic Acid—migraine	0.0001	0.000854	CcSEcCtD
Irbesartan—Cough—Timolol—migraine	0.0001	0.000853	CcSEcCtD
Irbesartan—Tremor—Gabapentin—migraine	0.0001	0.000853	CcSEcCtD
Irbesartan—Visual impairment—Topiramate—migraine	9.94e-05	0.000848	CcSEcCtD
Irbesartan—CYP3A4—central nervous system—migraine	9.92e-05	0.006	CbGeAlD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	9.91e-05	0.00193	CbGpPWpGaD
Irbesartan—Ill-defined disorder—Gabapentin—migraine	9.9e-05	0.000845	CcSEcCtD
Irbesartan—Hypertension—Timolol—migraine	9.89e-05	0.000844	CcSEcCtD
Irbesartan—Anaemia—Gabapentin—migraine	9.86e-05	0.000841	CcSEcCtD
Irbesartan—EDNRA—GPCR ligand binding—HTR7—migraine	9.85e-05	0.00192	CbGpPWpGaD
Irbesartan—Hypotension—Valproic Acid—migraine	9.82e-05	0.000837	CcSEcCtD
Irbesartan—Agitation—Gabapentin—migraine	9.81e-05	0.000837	CcSEcCtD
Irbesartan—Dizziness—Verapamil—migraine	9.8e-05	0.000836	CcSEcCtD
Irbesartan—CYP2D6—central nervous system—migraine	9.77e-05	0.00591	CbGeAlD
Irbesartan—Arthralgia—Timolol—migraine	9.76e-05	0.000832	CcSEcCtD
Irbesartan—Chest pain—Timolol—migraine	9.76e-05	0.000832	CcSEcCtD
Irbesartan—Myalgia—Timolol—migraine	9.76e-05	0.000832	CcSEcCtD
Irbesartan—Angioedema—Gabapentin—migraine	9.75e-05	0.000832	CcSEcCtD
Irbesartan—Anxiety—Timolol—migraine	9.72e-05	0.000829	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	9.69e-05	0.000827	CcSEcCtD
Irbesartan—Discomfort—Timolol—migraine	9.64e-05	0.000822	CcSEcCtD
Irbesartan—Malaise—Gabapentin—migraine	9.62e-05	0.000821	CcSEcCtD
Irbesartan—Tinnitus—Topiramate—migraine	9.62e-05	0.00082	CcSEcCtD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	9.6e-05	0.00187	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—FOS—migraine	9.6e-05	0.00187	CbGpPWpGaD
Irbesartan—Vertigo—Gabapentin—migraine	9.59e-05	0.000818	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Valproic Acid—migraine	9.57e-05	0.000817	CcSEcCtD
Irbesartan—Cardiac disorder—Topiramate—migraine	9.57e-05	0.000817	CcSEcCtD
Irbesartan—Flushing—Topiramate—migraine	9.57e-05	0.000817	CcSEcCtD
Irbesartan—Syncope—Gabapentin—migraine	9.57e-05	0.000816	CcSEcCtD
Irbesartan—Nausea—Propranolol—migraine	9.57e-05	0.000816	CcSEcCtD
Irbesartan—Leukopenia—Gabapentin—migraine	9.55e-05	0.000815	CcSEcCtD
Irbesartan—CYP2D6—cerebellum—migraine	9.55e-05	0.00577	CbGeAlD
Irbesartan—Dry mouth—Timolol—migraine	9.54e-05	0.000814	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—HTR2B—migraine	9.53e-05	0.00186	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—HTR1B—migraine	9.49e-05	0.00185	CbGpPWpGaD
Irbesartan—Paraesthesia—Valproic Acid—migraine	9.43e-05	0.000805	CcSEcCtD
Irbesartan—PTGS1—brain—migraine	9.43e-05	0.0057	CbGeAlD
Irbesartan—Vomiting—Verapamil—migraine	9.42e-05	0.000804	CcSEcCtD
Irbesartan—Loss of consciousness—Gabapentin—migraine	9.38e-05	0.0008	CcSEcCtD
Irbesartan—Dyspnoea—Valproic Acid—migraine	9.37e-05	0.000799	CcSEcCtD
Irbesartan—Angiopathy—Topiramate—migraine	9.36e-05	0.000798	CcSEcCtD
Irbesartan—Oedema—Timolol—migraine	9.35e-05	0.000798	CcSEcCtD
Irbesartan—Anaphylactic shock—Timolol—migraine	9.35e-05	0.000798	CcSEcCtD
Irbesartan—Rash—Verapamil—migraine	9.34e-05	0.000797	CcSEcCtD
Irbesartan—Somnolence—Valproic Acid—migraine	9.34e-05	0.000797	CcSEcCtD
Irbesartan—Dermatitis—Verapamil—migraine	9.33e-05	0.000796	CcSEcCtD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—BDNF—migraine	9.33e-05	0.00182	CbGpPWpGaD
Irbesartan—Immune system disorder—Topiramate—migraine	9.32e-05	0.000795	CcSEcCtD
Irbesartan—JUN—TGF-beta Receptor Signaling—TNF—migraine	9.32e-05	0.00182	CbGpPWpGaD
Irbesartan—Cough—Gabapentin—migraine	9.31e-05	0.000794	CcSEcCtD
Irbesartan—Mediastinal disorder—Topiramate—migraine	9.3e-05	0.000793	CcSEcCtD
Irbesartan—Infection—Timolol—migraine	9.29e-05	0.000793	CcSEcCtD
Irbesartan—Headache—Verapamil—migraine	9.28e-05	0.000792	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—HTR2A—migraine	9.27e-05	0.00181	CbGpPWpGaD
Irbesartan—Chills—Topiramate—migraine	9.25e-05	0.000789	CcSEcCtD
Irbesartan—Dyspepsia—Valproic Acid—migraine	9.25e-05	0.000789	CcSEcCtD
Irbesartan—Hypertension—Gabapentin—migraine	9.21e-05	0.000786	CcSEcCtD
Irbesartan—JUN—Oxidative Stress Induced Senescence—FOS—migraine	9.21e-05	0.0018	CbGpPWpGaD
Irbesartan—Shock—Timolol—migraine	9.2e-05	0.000785	CcSEcCtD
Irbesartan—AGTR1—Allograft Rejection—TNF—migraine	9.2e-05	0.00179	CbGpPWpGaD
Irbesartan—Nervous system disorder—Timolol—migraine	9.17e-05	0.000782	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—HTR1A—migraine	9.14e-05	0.00178	CbGpPWpGaD
Irbesartan—Decreased appetite—Valproic Acid—migraine	9.13e-05	0.000779	CcSEcCtD
Irbesartan—Arthralgia—Gabapentin—migraine	9.09e-05	0.000775	CcSEcCtD
Irbesartan—Chest pain—Gabapentin—migraine	9.09e-05	0.000775	CcSEcCtD
Irbesartan—Myalgia—Gabapentin—migraine	9.09e-05	0.000775	CcSEcCtD
Irbesartan—Skin disorder—Timolol—migraine	9.08e-05	0.000775	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Valproic Acid—migraine	9.07e-05	0.000774	CcSEcCtD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.06e-05	0.00177	CbGpPWpGaD
Irbesartan—Fatigue—Valproic Acid—migraine	9.06e-05	0.000773	CcSEcCtD
Irbesartan—Anxiety—Gabapentin—migraine	9.05e-05	0.000772	CcSEcCtD
Irbesartan—Hyperhidrosis—Timolol—migraine	9.04e-05	0.000771	CcSEcCtD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	9.03e-05	0.00176	CbGpPWpGaD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	9.02e-05	0.00077	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—NPS—migraine	9e-05	0.00176	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—TAC1—migraine	9e-05	0.00176	CbGpPWpGaD
Irbesartan—Constipation—Valproic Acid—migraine	8.98e-05	0.000766	CcSEcCtD
Irbesartan—Pain—Valproic Acid—migraine	8.98e-05	0.000766	CcSEcCtD
Irbesartan—Erythema—Topiramate—migraine	8.98e-05	0.000766	CcSEcCtD
Irbesartan—Malnutrition—Topiramate—migraine	8.98e-05	0.000766	CcSEcCtD
Irbesartan—Discomfort—Gabapentin—migraine	8.98e-05	0.000766	CcSEcCtD
Irbesartan—Anorexia—Timolol—migraine	8.92e-05	0.00076	CcSEcCtD
Irbesartan—Dry mouth—Gabapentin—migraine	8.89e-05	0.000758	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—HTR1D—migraine	8.85e-05	0.00173	CbGpPWpGaD
Irbesartan—JUN—PDGFR-beta signaling pathway—FOS—migraine	8.85e-05	0.00173	CbGpPWpGaD
Irbesartan—Flatulence—Topiramate—migraine	8.85e-05	0.000755	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—HTR2C—migraine	8.83e-05	0.00172	CbGpPWpGaD
Irbesartan—Tension—Topiramate—migraine	8.81e-05	0.000752	CcSEcCtD
Irbesartan—Nausea—Verapamil—migraine	8.8e-05	0.000751	CcSEcCtD
Irbesartan—Dysgeusia—Topiramate—migraine	8.79e-05	0.00075	CcSEcCtD
Irbesartan—Hypotension—Timolol—migraine	8.74e-05	0.000746	CcSEcCtD
Irbesartan—Nervousness—Topiramate—migraine	8.72e-05	0.000744	CcSEcCtD
Irbesartan—Anaphylactic shock—Gabapentin—migraine	8.71e-05	0.000743	CcSEcCtD
Irbesartan—Oedema—Gabapentin—migraine	8.71e-05	0.000743	CcSEcCtD
Irbesartan—Feeling abnormal—Valproic Acid—migraine	8.66e-05	0.000739	CcSEcCtD
Irbesartan—Infection—Gabapentin—migraine	8.65e-05	0.000738	CcSEcCtD
Irbesartan—Muscle spasms—Topiramate—migraine	8.63e-05	0.000736	CcSEcCtD
Irbesartan—Gastrointestinal pain—Valproic Acid—migraine	8.59e-05	0.000733	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—EDNRA—migraine	8.58e-05	0.00167	CbGpPWpGaD
Irbesartan—Shock—Gabapentin—migraine	8.57e-05	0.000731	CcSEcCtD
Irbesartan—Nervous system disorder—Gabapentin—migraine	8.54e-05	0.000729	CcSEcCtD
Irbesartan—Thrombocytopenia—Gabapentin—migraine	8.53e-05	0.000727	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Timolol—migraine	8.52e-05	0.000727	CcSEcCtD
Irbesartan—Tachycardia—Gabapentin—migraine	8.5e-05	0.000725	CcSEcCtD
Irbesartan—JUN—TGF-beta Signaling Pathway—FOS—migraine	8.48e-05	0.00165	CbGpPWpGaD
Irbesartan—Vision blurred—Topiramate—migraine	8.46e-05	0.000722	CcSEcCtD
Irbesartan—Skin disorder—Gabapentin—migraine	8.46e-05	0.000722	CcSEcCtD
Irbesartan—JUN—Integrated Breast Cancer Pathway—ESR1—migraine	8.45e-05	0.00165	CbGpPWpGaD
Irbesartan—Hyperhidrosis—Gabapentin—migraine	8.42e-05	0.000718	CcSEcCtD
Irbesartan—Tremor—Topiramate—migraine	8.41e-05	0.000718	CcSEcCtD
Irbesartan—Paraesthesia—Timolol—migraine	8.4e-05	0.000716	CcSEcCtD
Irbesartan—Urticaria—Valproic Acid—migraine	8.35e-05	0.000712	CcSEcCtD
Irbesartan—Dyspnoea—Timolol—migraine	8.34e-05	0.000711	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—RAMP1—migraine	8.33e-05	0.00163	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CALCRL—migraine	8.33e-05	0.00163	CbGpPWpGaD
Irbesartan—Ill-defined disorder—Topiramate—migraine	8.33e-05	0.000711	CcSEcCtD
Irbesartan—Somnolence—Timolol—migraine	8.31e-05	0.000709	CcSEcCtD
Irbesartan—Abdominal pain—Valproic Acid—migraine	8.31e-05	0.000708	CcSEcCtD
Irbesartan—Body temperature increased—Valproic Acid—migraine	8.31e-05	0.000708	CcSEcCtD
Irbesartan—Anorexia—Gabapentin—migraine	8.3e-05	0.000708	CcSEcCtD
Irbesartan—Anaemia—Topiramate—migraine	8.3e-05	0.000708	CcSEcCtD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	8.3e-05	0.00162	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CALCA—migraine	8.26e-05	0.00161	CbGpPWpGaD
Irbesartan—Agitation—Topiramate—migraine	8.25e-05	0.000704	CcSEcCtD
Irbesartan—Dyspepsia—Timolol—migraine	8.23e-05	0.000702	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2B—migraine	8.23e-05	0.00161	CbGpPWpGaD
Irbesartan—Hypotension—Gabapentin—migraine	8.14e-05	0.000694	CcSEcCtD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—FOS—migraine	8.13e-05	0.00159	CbGpPWpGaD
Irbesartan—Decreased appetite—Timolol—migraine	8.13e-05	0.000694	CcSEcCtD
Irbesartan—Malaise—Topiramate—migraine	8.1e-05	0.000691	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Timolol—migraine	8.07e-05	0.000689	CcSEcCtD
Irbesartan—Vertigo—Topiramate—migraine	8.07e-05	0.000688	CcSEcCtD
Irbesartan—Fatigue—Timolol—migraine	8.06e-05	0.000688	CcSEcCtD
Irbesartan—Syncope—Topiramate—migraine	8.05e-05	0.000687	CcSEcCtD
Irbesartan—JUN—Toll-Like Receptors Cascades—FOS—migraine	8.04e-05	0.00157	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR1D—migraine	8.04e-05	0.00157	CbGpPWpGaD
Irbesartan—Leukopenia—Topiramate—migraine	8.04e-05	0.000686	CcSEcCtD
Irbesartan—Pain—Timolol—migraine	8e-05	0.000682	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Gabapentin—migraine	7.94e-05	0.000677	CcSEcCtD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—TNF—migraine	7.93e-05	0.00155	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—FOS—migraine	7.91e-05	0.00154	CbGpPWpGaD
Irbesartan—Loss of consciousness—Topiramate—migraine	7.89e-05	0.000673	CcSEcCtD
Irbesartan—Cough—Topiramate—migraine	7.83e-05	0.000668	CcSEcCtD
Irbesartan—Paraesthesia—Gabapentin—migraine	7.82e-05	0.000667	CcSEcCtD
Irbesartan—Dyspnoea—Gabapentin—migraine	7.77e-05	0.000662	CcSEcCtD
Irbesartan—CYP2D6—brain—migraine	7.75e-05	0.00469	CbGeAlD
Irbesartan—Hypertension—Topiramate—migraine	7.75e-05	0.000661	CcSEcCtD
Irbesartan—Somnolence—Gabapentin—migraine	7.74e-05	0.00066	CcSEcCtD
Irbesartan—Hypersensitivity—Valproic Acid—migraine	7.74e-05	0.00066	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—HTR7—migraine	7.73e-05	0.00151	CbGpPWpGaD
Irbesartan—Feeling abnormal—Timolol—migraine	7.71e-05	0.000657	CcSEcCtD
Irbesartan—Dyspepsia—Gabapentin—migraine	7.67e-05	0.000654	CcSEcCtD
Irbesartan—Gastrointestinal pain—Timolol—migraine	7.65e-05	0.000652	CcSEcCtD
Irbesartan—Arthralgia—Topiramate—migraine	7.64e-05	0.000652	CcSEcCtD
Irbesartan—Chest pain—Topiramate—migraine	7.64e-05	0.000652	CcSEcCtD
Irbesartan—Myalgia—Topiramate—migraine	7.64e-05	0.000652	CcSEcCtD
Irbesartan—Anxiety—Topiramate—migraine	7.62e-05	0.00065	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.59e-05	0.000648	CcSEcCtD
Irbesartan—Decreased appetite—Gabapentin—migraine	7.57e-05	0.000646	CcSEcCtD
Irbesartan—Discomfort—Topiramate—migraine	7.55e-05	0.000644	CcSEcCtD
Irbesartan—Asthenia—Valproic Acid—migraine	7.54e-05	0.000643	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Gabapentin—migraine	7.52e-05	0.000641	CcSEcCtD
Irbesartan—Fatigue—Gabapentin—migraine	7.51e-05	0.000641	CcSEcCtD
Irbesartan—Dry mouth—Topiramate—migraine	7.48e-05	0.000638	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—HTR2B—migraine	7.48e-05	0.00146	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—FOS—migraine	7.45e-05	0.00145	CbGpPWpGaD
Irbesartan—Pain—Gabapentin—migraine	7.45e-05	0.000635	CcSEcCtD
Irbesartan—Constipation—Gabapentin—migraine	7.45e-05	0.000635	CcSEcCtD
Irbesartan—Pruritus—Valproic Acid—migraine	7.43e-05	0.000634	CcSEcCtD
Irbesartan—Urticaria—Timolol—migraine	7.43e-05	0.000634	CcSEcCtD
Irbesartan—Abdominal pain—Timolol—migraine	7.39e-05	0.000631	CcSEcCtD
Irbesartan—Body temperature increased—Timolol—migraine	7.39e-05	0.000631	CcSEcCtD
Irbesartan—Oedema—Topiramate—migraine	7.33e-05	0.000625	CcSEcCtD
Irbesartan—Infection—Topiramate—migraine	7.28e-05	0.000621	CcSEcCtD
Irbesartan—JUN—Insulin Signaling—FOS—migraine	7.27e-05	0.00142	CbGpPWpGaD
Irbesartan—Shock—Topiramate—migraine	7.21e-05	0.000615	CcSEcCtD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—FOS—migraine	7.2e-05	0.0014	CbGpPWpGaD
Irbesartan—Diarrhoea—Valproic Acid—migraine	7.19e-05	0.000613	CcSEcCtD
Irbesartan—Nervous system disorder—Topiramate—migraine	7.19e-05	0.000613	CcSEcCtD
Irbesartan—Feeling abnormal—Gabapentin—migraine	7.18e-05	0.000612	CcSEcCtD
Irbesartan—Thrombocytopenia—Topiramate—migraine	7.17e-05	0.000612	CcSEcCtD
Irbesartan—Tachycardia—Topiramate—migraine	7.15e-05	0.00061	CcSEcCtD
Irbesartan—Gastrointestinal pain—Gabapentin—migraine	7.12e-05	0.000608	CcSEcCtD
Irbesartan—Skin disorder—Topiramate—migraine	7.12e-05	0.000607	CcSEcCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.11e-05	0.00139	CbGpPWpGaD
Irbesartan—Hyperhidrosis—Topiramate—migraine	7.08e-05	0.000604	CcSEcCtD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—ESR1—migraine	7e-05	0.00137	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—FOS—migraine	6.99e-05	0.00136	CbGpPWpGaD
Irbesartan—Anorexia—Topiramate—migraine	6.98e-05	0.000596	CcSEcCtD
Irbesartan—Dizziness—Valproic Acid—migraine	6.95e-05	0.000593	CcSEcCtD
Irbesartan—Urticaria—Gabapentin—migraine	6.92e-05	0.00059	CcSEcCtD
Irbesartan—EDNRA—GPCR ligand binding—HTR2A—migraine	6.9e-05	0.00135	CbGpPWpGaD
Irbesartan—Hypersensitivity—Timolol—migraine	6.89e-05	0.000588	CcSEcCtD
Irbesartan—Abdominal pain—Gabapentin—migraine	6.89e-05	0.000587	CcSEcCtD
Irbesartan—Body temperature increased—Gabapentin—migraine	6.89e-05	0.000587	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	6.86e-05	0.00134	CbGpPWpGaD
Irbesartan—Hypotension—Topiramate—migraine	6.85e-05	0.000584	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—HTR1B—migraine	6.84e-05	0.00133	CbGpPWpGaD
Irbesartan—Asthenia—Timolol—migraine	6.71e-05	0.000572	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—FOS—migraine	6.7e-05	0.00131	CbGpPWpGaD
Irbesartan—Vomiting—Valproic Acid—migraine	6.68e-05	0.00057	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Topiramate—migraine	6.68e-05	0.000569	CcSEcCtD
Irbesartan—Rash—Valproic Acid—migraine	6.62e-05	0.000565	CcSEcCtD
Irbesartan—Dermatitis—Valproic Acid—migraine	6.62e-05	0.000565	CcSEcCtD
Irbesartan—Pruritus—Timolol—migraine	6.62e-05	0.000564	CcSEcCtD
Irbesartan—Headache—Valproic Acid—migraine	6.58e-05	0.000561	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—HTR1A—migraine	6.58e-05	0.00128	CbGpPWpGaD
Irbesartan—Paraesthesia—Topiramate—migraine	6.58e-05	0.000561	CcSEcCtD
Irbesartan—JUN—Apoptosis—TNF—migraine	6.54e-05	0.00128	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RAMP1—migraine	6.54e-05	0.00128	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CALCRL—migraine	6.54e-05	0.00128	CbGpPWpGaD
Irbesartan—Dyspnoea—Topiramate—migraine	6.53e-05	0.000557	CcSEcCtD
Irbesartan—Somnolence—Topiramate—migraine	6.51e-05	0.000556	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—TAC1—migraine	6.48e-05	0.00126	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—NPS—migraine	6.48e-05	0.00126	CbGpPWpGaD
Irbesartan—Dyspepsia—Topiramate—migraine	6.45e-05	0.00055	CcSEcCtD
Irbesartan—JUN—Cellular Senescence—FOS—migraine	6.44e-05	0.00126	CbGpPWpGaD
Irbesartan—Hypersensitivity—Gabapentin—migraine	6.42e-05	0.000547	CcSEcCtD
Irbesartan—Diarrhoea—Timolol—migraine	6.4e-05	0.000546	CcSEcCtD
Irbesartan—Decreased appetite—Topiramate—migraine	6.37e-05	0.000543	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2C—migraine	6.36e-05	0.00124	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Topiramate—migraine	6.33e-05	0.00054	CcSEcCtD
Irbesartan—Fatigue—Topiramate—migraine	6.32e-05	0.000539	CcSEcCtD
Irbesartan—Pain—Topiramate—migraine	6.27e-05	0.000535	CcSEcCtD
Irbesartan—Constipation—Topiramate—migraine	6.27e-05	0.000535	CcSEcCtD
Irbesartan—Asthenia—Gabapentin—migraine	6.25e-05	0.000533	CcSEcCtD
Irbesartan—Nausea—Valproic Acid—migraine	6.24e-05	0.000532	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—HTR1B—migraine	6.21e-05	0.00121	CbGpPWpGaD
Irbesartan—Dizziness—Timolol—migraine	6.18e-05	0.000528	CcSEcCtD
Irbesartan—Pruritus—Gabapentin—migraine	6.16e-05	0.000526	CcSEcCtD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—migraine	6.08e-05	0.00119	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR1D—migraine	6.05e-05	0.00118	CbGpPWpGaD
Irbesartan—Feeling abnormal—Topiramate—migraine	6.04e-05	0.000515	CcSEcCtD
Irbesartan—Gastrointestinal pain—Topiramate—migraine	5.99e-05	0.000511	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—HTR1A—migraine	5.98e-05	0.00117	CbGpPWpGaD
Irbesartan—Diarrhoea—Gabapentin—migraine	5.96e-05	0.000508	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—CALCA—migraine	5.95e-05	0.00116	CbGpPWpGaD
Irbesartan—Vomiting—Timolol—migraine	5.95e-05	0.000507	CcSEcCtD
Irbesartan—Rash—Timolol—migraine	5.9e-05	0.000503	CcSEcCtD
Irbesartan—Dermatitis—Timolol—migraine	5.89e-05	0.000503	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—NPS—migraine	5.89e-05	0.00115	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TAC1—migraine	5.89e-05	0.00115	CbGpPWpGaD
Irbesartan—Headache—Timolol—migraine	5.86e-05	0.0005	CcSEcCtD
Irbesartan—Urticaria—Topiramate—migraine	5.82e-05	0.000497	CcSEcCtD
Irbesartan—Body temperature increased—Topiramate—migraine	5.79e-05	0.000494	CcSEcCtD
Irbesartan—Abdominal pain—Topiramate—migraine	5.79e-05	0.000494	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—HTR2C—migraine	5.77e-05	0.00113	CbGpPWpGaD
Irbesartan—Dizziness—Gabapentin—migraine	5.76e-05	0.000491	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—HTR2B—migraine	5.63e-05	0.0011	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—migraine	5.6e-05	0.00109	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR7—migraine	5.57e-05	0.00109	CbGpPWpGaD
Irbesartan—Nausea—Timolol—migraine	5.56e-05	0.000474	CcSEcCtD
Irbesartan—Vomiting—Gabapentin—migraine	5.54e-05	0.000472	CcSEcCtD
Irbesartan—Rash—Gabapentin—migraine	5.49e-05	0.000468	CcSEcCtD
Irbesartan—Dermatitis—Gabapentin—migraine	5.49e-05	0.000468	CcSEcCtD
Irbesartan—UGT1A3—Metabolism—CACNA1A—migraine	5.49e-05	0.00107	CbGpPWpGaD
Irbesartan—Headache—Gabapentin—migraine	5.46e-05	0.000465	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—HTR2A—migraine	5.41e-05	0.00106	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CALCA—migraine	5.4e-05	0.00105	CbGpPWpGaD
Irbesartan—Hypersensitivity—Topiramate—migraine	5.4e-05	0.000461	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—HTR1B—migraine	5.36e-05	0.00105	CbGpPWpGaD
Irbesartan—Asthenia—Topiramate—migraine	5.26e-05	0.000448	CcSEcCtD
Irbesartan—Pruritus—Topiramate—migraine	5.18e-05	0.000442	CcSEcCtD
Irbesartan—Nausea—Gabapentin—migraine	5.17e-05	0.000441	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—HTR1A—migraine	5.16e-05	0.00101	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—NPS—migraine	5.09e-05	0.000992	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—TAC1—migraine	5.09e-05	0.000992	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR7—migraine	5.06e-05	0.000986	CbGpPWpGaD
Irbesartan—Diarrhoea—Topiramate—migraine	5.01e-05	0.000428	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2C—migraine	4.99e-05	0.000973	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LRP1—migraine	4.95e-05	0.000967	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CALCRL—migraine	4.88e-05	0.000953	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RAMP1—migraine	4.88e-05	0.000953	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR1B—migraine	4.87e-05	0.00095	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—FOS—migraine	4.87e-05	0.00095	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—EDNRA—migraine	4.85e-05	0.000946	CbGpPWpGaD
Irbesartan—Dizziness—Topiramate—migraine	4.85e-05	0.000413	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—HTR1D—migraine	4.75e-05	0.000927	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR1A—migraine	4.69e-05	0.000915	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CALCA—migraine	4.67e-05	0.000911	CbGpPWpGaD
Irbesartan—Vomiting—Topiramate—migraine	4.66e-05	0.000397	CcSEcCtD
Irbesartan—Rash—Topiramate—migraine	4.62e-05	0.000394	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—TAC1—migraine	4.62e-05	0.000901	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—NPS—migraine	4.62e-05	0.000901	CbGpPWpGaD
Irbesartan—Dermatitis—Topiramate—migraine	4.62e-05	0.000394	CcSEcCtD
Irbesartan—Headache—Topiramate—migraine	4.59e-05	0.000392	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—HTR2C—migraine	4.53e-05	0.000884	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2B—migraine	4.42e-05	0.000861	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EDNRA—migraine	4.41e-05	0.000859	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—migraine	4.4e-05	0.000858	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—migraine	4.37e-05	0.000853	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR7—migraine	4.37e-05	0.000852	CbGpPWpGaD
Irbesartan—Nausea—Topiramate—migraine	4.35e-05	0.000371	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CALCA—migraine	4.24e-05	0.000827	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—migraine	3.99e-05	0.000778	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR7—migraine	3.97e-05	0.000774	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—HTR2A—migraine	3.9e-05	0.000761	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LRP1—migraine	3.89e-05	0.000758	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOTCH4—migraine	3.8e-05	0.000742	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—migraine	3.76e-05	0.000733	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR1B—migraine	3.67e-05	0.000715	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1D—migraine	3.55e-05	0.000692	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—HTR2A—migraine	3.54e-05	0.000691	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR1A—migraine	3.53e-05	0.000689	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TAC1—migraine	3.48e-05	0.000678	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NPS—migraine	3.48e-05	0.000678	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PGR—migraine	3.48e-05	0.000678	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2C—migraine	3.41e-05	0.000665	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.39e-05	0.000662	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	3.32e-05	0.000648	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	3.32e-05	0.000648	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2B—migraine	3.3e-05	0.000644	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOTCH3—migraine	3.23e-05	0.000631	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CALCA—migraine	3.19e-05	0.000623	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CACNA1A—migraine	3.09e-05	0.000603	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—HTR2A—migraine	3.06e-05	0.000597	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR7—migraine	2.99e-05	0.000583	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOTCH4—migraine	2.98e-05	0.000582	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LRP1—migraine	2.9e-05	0.000567	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR1B—migraine	2.88e-05	0.000561	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—HTR2A—migraine	2.78e-05	0.000542	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR1A—migraine	2.77e-05	0.00054	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PGR—migraine	2.73e-05	0.000532	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TAC1—migraine	2.73e-05	0.000532	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NPS—migraine	2.73e-05	0.000532	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2C—migraine	2.68e-05	0.000522	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FOS—migraine	2.6e-05	0.000508	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EDNRA—migraine	2.6e-05	0.000508	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFBR2—migraine	2.57e-05	0.000502	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOTCH3—migraine	2.54e-05	0.000495	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CALCA—migraine	2.51e-05	0.000489	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR7—migraine	2.34e-05	0.000457	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOTCH4—migraine	2.23e-05	0.000435	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1B—migraine	2.15e-05	0.000419	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2A—migraine	2.09e-05	0.000408	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1A—migraine	2.07e-05	0.000404	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TAC1—migraine	2.04e-05	0.000398	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NPS—migraine	2.04e-05	0.000398	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PGR—migraine	2.04e-05	0.000398	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFBR2—migraine	2.02e-05	0.000394	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2C—migraine	2e-05	0.00039	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CACNA1A—migraine	2e-05	0.000389	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EDNRA—migraine	1.94e-05	0.000379	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOTCH3—migraine	1.89e-05	0.00037	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CALCA—migraine	1.87e-05	0.000365	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ESR1—migraine	1.86e-05	0.000362	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—migraine	1.81e-05	0.000354	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR7—migraine	1.75e-05	0.000342	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—migraine	1.64e-05	0.00032	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNA1A—migraine	1.64e-05	0.00032	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNA1A—migraine	1.62e-05	0.000317	CbGpPWpGaD
Irbesartan—JUN—Immune System—FOS—migraine	1.52e-05	0.000296	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFBR2—migraine	1.51e-05	0.000294	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ESR1—migraine	1.46e-05	0.000284	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1A—migraine	1.39e-05	0.000271	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—migraine	1.23e-05	0.000239	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ESR1—migraine	1.09e-05	0.000212	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1A—migraine	1.07e-05	0.000209	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—migraine	1.02e-05	0.000199	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—migraine	6.6e-06	0.000129	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—migraine	5.42e-06	0.000106	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—migraine	5.37e-06	0.000105	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—migraine	4.59e-06	8.96e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—migraine	3.54e-06	6.91e-05	CbGpPWpGaD
